Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of readmission after allogeneic hematopoietic cell transplantation.
Yamaguchi K, Inamoto Y, Tajima K, Sakatoku K, Kuno M, Kawajiri A, Takemura T, Tanaka T, Ito A, Kurosawa S, Kim SW, Fukuda T. Yamaguchi K, et al. Among authors: kuno m. Bone Marrow Transplant. 2021 Jun;56(6):1335-1340. doi: 10.1038/s41409-020-01190-w. Epub 2021 Jan 7. Bone Marrow Transplant. 2021. PMID: 33414511
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation.
Nakamae H, Nakane T, Okamura H, Koh H, Nakashima Y, Hirose A, Nakamae M, Nishimoto M, Kuno M, Makuuchi Y, Harada N, Takakuwa T, Hino M. Nakamae H, et al. Among authors: kuno m. Int J Hematol. 2022 Jan;115(1):77-86. doi: 10.1007/s12185-021-03228-1. Epub 2021 Sep 29. Int J Hematol. 2022. PMID: 34586587 Clinical Trial.
Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation.
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Kuno M, et al. Am J Hematol. 2022 Feb 1;97(2):185-193. doi: 10.1002/ajh.26401. Epub 2021 Nov 16. Am J Hematol. 2022. PMID: 34738245 Free article.
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation.
Harada N, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Nishimoto M, Nakashima Y, Koh H, Bingo M, Higashimori A, Fujiwara Y, Hino M, Nakamae H. Harada N, et al. Among authors: kuno m. Ann Hematol. 2022 Nov;101(11):2567-2569. doi: 10.1007/s00277-022-04970-0. Epub 2022 Aug 31. Ann Hematol. 2022. PMID: 36045181 No abstract available.
Effect of graft cell dose on second transplantation from a haploidentical donor with post-transplantation cyclophosphamide for relapsed/refractory acute leukemia.
Nakaya Y, Nakamae H, Harada N, Okamura H, Sakatoku K, Ido K, Makuuchi Y, Kuno M, Takakuwa T, Hirose A, Nakamae M, Nishimoto M, Nakashima Y, Koh H, Hino M. Nakaya Y, et al. Among authors: kuno m. Bone Marrow Transplant. 2023 Aug;58(8):947-949. doi: 10.1038/s41409-023-01986-6. Epub 2023 Apr 28. Bone Marrow Transplant. 2023. PMID: 37117265 No abstract available.
Sinusoidal obstruction syndrome associated with disseminated toxoplasmosis involving the liver after allogeneic hematopoietic stem cell transplantation: A case report.
Makuuchi Y, Tanaka S, Koh H, Niki M, Norose K, Nakaya Y, Ido K, Sakatoku K, Kuno M, Harada N, Takakuwa T, Hirose A, Okamura H, Nishimoto M, Nakashima Y, Nakamae M, Hikosaka K, Kakeya H, Ohsawa M, Hino M, Nakamae H. Makuuchi Y, et al. Among authors: kuno m. J Infect Chemother. 2023 Sep;29(9):909-912. doi: 10.1016/j.jiac.2023.05.009. Epub 2023 May 17. J Infect Chemother. 2023. PMID: 37207959
392 results